Page 357«..1020..356357358359..370380..»

Cloning and Stem Cells | Biological Principles

Posted: July 3, 2022 at 2:26 am

Learning Objectives

Gene therapy works best by genetically repairing a patients stem cells. The easiest source of stem cells are from early embryos. The intersection of stem cell technology, genetic engineering, and cloning poses both scientific and ethical challenges.

Many organisms, such as bacteria and archaea, and diverse eukaryotes, reproduce asexually. Asexual reproduction results in progeny that are genetically identical to the parent, meaning that they are clones of the parent.

Most complex, multicellular eukaryotes, however, reproduce only sexually. Two haploid gametes unite to form a diploid cell, called a zygote, that reproduces mitotically to form all the somatic cells of a complex multicellular organism. During mitotic cell divisions, various cells express different sets of genes to differentiate into different organs, tissues, and cell types. Two fundamental questions of biology are: 1) how genes regulate the process of development, and 2) whether somatic cells undergo irreversible genetic changes as they differentiate.

Early experiments with cloning plants showed that individual somatic cells (cells that do not form pollen or egg) could form complete, new clonal plants, indicating that the somatic cells had no irreversible changes in their genome compared to the original fertilized egg cell.

The first studies to test whether vertebrate animals could be cloned used a technique called somatic cell nuclear transfer (SCNT), where nuclei from somatic cells were transferred to an egg cell whose own nucleus had been removed.

Somatic cell nuclear transfer, from Wikipedia. Transfer of a nucleus from a differentiated somatic cell into an enucleated egg cell creates a one-cell embryo that is genetically identical to the donor of the somatic cell nucleus. The embryo is stimulated to divide to form an early-stage embryo consisting of multiple cells (labeled clone in the figure). In reproductive cloning, this early-stage embryo is implanted into the uterus of a surrogate mother. In therapeutic cloning, the early-stage embryo is disaggregated to recover and culture embryonic stem cells. Image source: https://commons.wikimedia.org/wiki/File:Cloning_diagram_english.svg cc-by-sa-3.0

Early studies with enucleated frog eggs found that donor nuclei from early embryos supported development of a complete adult animal, but nuclei from tadpoles or adult frogs could not. These early results suggested that as vertebrate animals progressed through embryonic development, birth, and aging, their somatic cell nuclei became programmed to differentiate into specialized cells, rather than support embryonic development. We now know that this programming involves reversible modification of chromatin that restricts what genes can be expressed in differentiated cells.

The short video below shows the SCNT process:

In 1996, Ian Wilmut and colleagues found that by arresting adult somatic cell cultures in the cell cycle, he could erase some or most of their nuclear programming. Using cultured mammary gland cells from an adult sheep as the source of donor nuclei, he performed 277 SCNTs to create clone embryos. The embryos that divided normally were implanted into the uterus of foster mother sheep. Only a single lamb, Dolly, was successfully born alive and healthy from the 277 attempts. Since then, many other mammalian species have been cloned, with success rates varying from a few to low tens of percent.

https://www.dnalc.org/view/16992-Cloning-101.html

Mammalian reproductive cloning is still inefficient, with a low success rate, complications during pregnancy, and possible premature aging of the cloned offspring (https://learn.genetics.utah.edu/content/tech/cloning/cloningrisks/). As far as we know, no reproductive cloning of humans has yet been attempted.

The human body is quite limited in its ability to regenerate or repair injuries or diseases that affect critical organs such as the brain, heart, and pancreas. Tissue and organ regeneration and gene therapy require a source of cells that can differentiate into the desired types of cells, for the life of the patient. Adult humans have distinct reservoirs of stem cells, located in different parts of the body (such as the bone marrow). Stem cells, by definition, can continue to divide and both replace themselves and produce progeny cells that differentiate into new blood and immune system cells, or skin cells, or cells that line the gut and airways, or muscle cells. But these adult stem cells are difficult to obtain from a patient, and they are restricted in the types of cells or tissues they can form. For example, the stem cells in the bone marrow can generate both white and red blood cells, but not skin cells or new brain cells or heart muscle or pancreatic beta islet cells (to cure diabetes).

Cells in an early human embryo, however, are totipotent or pluripotent they can form any part of the human body. Such cells can be cultured indefinitely as embryonic stem cell lines. Existing human embryonic stem cell lines have been derived from in-vitro fertilized, early-stage human embryos, that would have perished without implantation into a uterus. These were surplus or back-up embryos from fertility clinics, that would have been discarded or put into indefinite cryo-storage.

Therapeutic cloning uses enucleated human eggs and somatic cell nuclear transfer technology to create a human embryo that is a genetic clone of the patient. The embryo is destroyed to obtain embryonic stem cells that have the same genotype as the patient. These cells can be cultured indefinitely, and hormonally induced to form new tissues and organs that will not be rejected by the patients immune system.

Link here to a narrated animation on Human Embryonic Stem Cells (Sumanas Inc)

In the last decade, genetic engineering technology has been used to create a new type of stem cell: induced pluripotent stem cells (iPSCs). These cells, created by transforming adult differentiated cells (such as fibroblasts or skin cells) with 4-6 different transcription factors that regulate early embryonic cell growth and differentiation, have many of the properties of embryonic stem cells. The question is whether these transcription factor genes can be safely used to transform the patients own cells without causing unacceptably high risks of cancer once these cells are reintroduced into the patients body. Because iPSCs do not involve destruction of human embryos, they have been the focus of intense research. A review by Wilson and Wu (2015) provides a concise description of the state of the research and the challenges in this field.

Stem cells, depending on whether they were obtained from adults, embryos, or induced with transcription factors, can be induced to differentiate into different cell types to generate replacement organs and repair damaged heart muscle, pancreatic beta cells, spinal cord or brain cells. Coupled with genome editing, stem cells could be used to treat patients with genetic disorders.

Slides for the videos above:

B1510_module5-2_Cloning_StemCells_2011

Wilson, KD and JC Wu (2015) Induced Pluripotent Stem Cells, JAMA. 313(16):1613-1614. doi:10.1001/jama.2015.1846

https://learn.genetics.utah.edu/content/tech/cloning/whatiscloning/

https://learn.genetics.utah.edu/content/tech/cloning/clickandclone/ go through the steps to clone a mouse using somatic cell nuclear transfer technology

Original post:
Cloning and Stem Cells | Biological Principles

Posted in Utah Stem Cells | Comments Off on Cloning and Stem Cells | Biological Principles

Effect of tensile frequency on osteogenic differentiation | IJGM – Dove Medical Press

Posted: July 3, 2022 at 2:26 am

Introduction

Mechanical stress enhances bone metabolism and periodontal tissue remodeling.1 During orthodontic tooth movement (OTM), bone remodeling is initiated via the periodontal ligament.2 As the main mesenchymal stem cells (MSCs) in the periodontal ligament, periodontal ligament stem cells (PDLSCs) play an important role in mechanical signal transduction. Currently, a consensus has been reached that cyclic mechanical tension is a strong driver of the differentiation of PDLSCs into the osteoblast lineage.24 Mechanical tension activates calcium channels,5 which activate the ERK1/2 and P38 MAPK pathways through integrin-FAK or protein kinase (PKC)-SR signaling6 and induce the phosphorylation of Runt-associated transcription factor 2 (Runx2),7 promoting osteogenic precursor cell synthesis and the transcription of mineralizable proteins.8 At present, the TGF-, BMP, MAPK, Notch, Wnt, Hedgehog, FGF, and Hippo signaling pathways have been found to be involved in this process.

Force parameters (including magnitude, frequency, and duration) are crucial for well-regulated tissue remodeling. However, numerous in vitro studies performed to date show enormous heterogeneity in tensile force parameters.9 In different studies, cyclic tension was applied with magnitudes ranging from 1% to 24%, frequencies ranging from 0.1 Hz to 1.0 Hz, and stimuli duration ranging from 1 hour to 6 days, thereby reducing comparability between different studies.9 To establish strategies to optimize tensile force parameters, it is of particular importance to understand how different tensile force parameters affect the osteogenic differentiation of PDLSCs.

The effects of different tensile force magnitudes and durations have been investigated in some studies. Among the magnitudes, a magnitude of 10% generally led to a lower level of inflammation and a higher level of osteogenesis,10 whereas a magnitude of 12% was found to correlate well with strain conditions at the mid-root under physiological loading conditions11,12 and to induce optimal effects in both the proliferation and osteogenesis of PDLSCs.13 Cyclic tension alone at 3000 strain significantly enhanced SATB Homeobox 2 (Satb2) after 3 h of loading and significantly upregulated Runx2 after 6 h.14 The synthesis of BMP9 increased under 6-h continuously applied cyclic tension.15 In addition, 12% cyclic tensile force gradually upregulated the expression of Runx2, alkaline phosphatase (ALP), and osteocalcin (OCN) with force durations of 6 h, 12 h, and 24 h, respectively.16,17 The protein level of osterix increased stepwise following 3 h, 6 h, 12 h, and 24 h of exposure to tensile strain.14 Recently, temporal gene expression patterns were delineated.17

Tensile frequency varies largely among different studies. The ROCKTAZ pathway and its interaction with Cbf1 were found to be essential for the cyclic tension (12% elongation, 0.1 Hz)-induced osteogenic differentiation in PDLSCs.18 Cyclic tension (10% elongation, 0.5 Hz) stimulated the osteogenic differentiation of PDLSCs by inhibiting miR-129-5p expression and activating the BMP2/Smad pathway.17 LncRNAs-miRNAs-mRNAs networks in PDLSCs were depicted under cyclic tension (10% elongation, 1.0 Hz).19 However, there have been rare studies examining the impact of different cyclic tensile frequencies on osteogenesis of PDLSCs and the expression of relevant genes thus far. The low-magnitude high-frequency (LMHF) vibration approach was excluded because it is used to simulate a masticatory force, while cyclic tension is used to simulate an orthodontic force, and the two methods of force application are completely different.2,20 Previous animal studies on long bone distraction osteogenesis have shown that loading frequency affects the osteogenic response of bone tissue.21 The mechano-regulation of trabecular bone adaptation is logarithmically dependent on the loading frequency.22 Therefore, we hypothesized that tensile frequency would affect osteogenesis of PDLSCs, in which some tensile frequency-sensitive genes may play an important role. To test our hypotheses, human PDLSCs were subjected to cyclic mechanical tension at different frequencies of 0.10.7 Hz to examine the osteoblastic differentiation of PDLSCs, and high-throughput sequencing was performed to characterize the frequency-course expression patterns of mRNA during the osteogenic differentiation of PDLSCs. This study aimed to investigate the effects of tensile frequency on the osteogenic differentiation of PDLSCs as well as the relevant molecular mechanisms.

Healthy periodontal ligament tissues were scraped from the middle third of tooth roots, which were extracted for orthodontic reasons, with informed consents. All donors were aged from 14 to 16 years and had no systemic or oral diseases. The periodontal ligament tissues were cut into small pieces and enzymatically digested for 40 min at 37C with collagenase I (3 mg/mL, Sigma-Aldrich, St. Louis, MO, USA) and dispase II (4 mg/mL; Sigma-Aldrich). The cells were seeded in 25 cm2 flasks (Falcon, BD Biosciences, Franklin Lakes, NJ, USA) with -minimal essential medium (-MEM; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS, Gibco, Life Technologies Co., Grand Island, NY, USA) and antibiotics (100 U/mL penicillin and 100 g/mL streptomycin, Hyclone, Logan, Utah, USA), and incubated in a humidified atmosphere (37C, 5% CO2). The medium was changed every 3 days. After reaching 80% of confluence, the cells were detached with 0.25% trypsin/EDTA (Gibco, Life Technologies Co., Grand Island, NY, USA), and single-cell suspensions were cloned with the limiting-dilution method to purify the stem cells.17 Cell clusters from the colony were trypsinized and serially sub-cultured.

The third-passage PDLSCs were sub-cultured into six-well plates until confluent. The culture medium was then removed, and cells were fixed with 4% formaldehyde (Zhonghuihecai, Xian, CN) for 20 min, permeabilized with 0.3% Triton X-100 (Zhonghuihecai) for 5 min, and incubated with primary antibodies (anti-pan-cytokeratin, 1:300, Abcam, Cambridge, MA, USA; anti-vimentin, 1:500, Abcam; anti-STRO-1, 1:200, Abcam; anti-CD146, 1:200, Abcam) overnight at 4C. The cells were then washed with PBS and incubated with CY3/FITC-conjugated secondary antibodies (1:500, Zhuangzhi, Xian, CN) in darkness for 30 min, and then washed with PBS. Finally, the nuclei were counterstained with 4, 6-diamidino-2-phenylindole (DAPI, Zhuangzhi), and fluorescent images were captured with a fluorescence microscope (Olympus, Japan).

For osteogenic and adipogenic differentiation, PDLSCs were seeded into six-well plates at a density of 2105 cells/well, and after reaching 80% confluence, the medium was replaced with an osteogenic or adipogenic inductive medium (Osteogenesis or Adipogenesis Differentiation Kit, Cyagen, USA). Seven days after osteogenic induction, the cells were stained with ALP (ALP staining kit, Solarbio, CN), and 14 days after osteogenic incubation, the cells were stained with Alizarin Red (ARS staining kit, Cyagen, USA). After 21 days of adipogenic incubation, the cells were stained with Oil Red O (Cyagen, USA).

Flexcell FX-5000T Tension Plus System (Flexcell International Corporation, Hillsborough, NC, USA) was used to mimic the tensile force exerted on PDLSCs during OTM, according to previous studies.23 Cyclic tensile loading experiments were performed on the fourth-passage PDLSCs from four different healthy donors in triplicate. PDLSCs were seeded onto six-well type I collagen (COL-I)-coated silicone culture plates (Flexcell International Corporation) at a density of 2105 cells/well. Upon reaching 80% confluence, the cells were serum-starved overnight, and the medium was changed to osteogenic medium (Cyagen, USA). Cyclic tensile force (12% bottom membrane elongation) was applied to different plates at different frequencies of 0.1 Hz, 0.5 Hz, and 0.7 Hz. Control cells were cultured under identical culture condition but without mechanical stimulation.

After 10 h of cyclic tensile force, the cells were collected. Proteins were isolated, electrophoretically separated, and immunoblotted as previously described.23 Briefly, PDLSCs were lysed with RIPA buffer containing 1% phenylmethanesulfonyl fluoride (PMSF, proteinase inhibitor, Zhonghuihecai) and 1% phosphatase inhibitor (Zhonghuihecai). After centrifugation, the supernatant was collected and measured quantitatively using a BCA Protein Assay Kit (Absin, Shanghai, CN). Total protein from cell lysates (20 g/lane) was separated by SDS-PAGE gels (Beyotime, Hangzhou, CN) and then transferred onto a polyvinylidene difluoride (PVDF) membrane (EMD Millipore, Billerica, MA, USA). After blocking with 5% skimmed milk in tris-buffered saline tween-20 (TBST) for 2 h at room temperature, the membranes were incubated overnight at 4C with primary antibodies (runt-related transcription factor 2 (Runx2), 1:500, ImmunoWay, USA; COL-I, 1:1000, Proteintech, USA; Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 1:10000, Proteintech, USA), followed by incubation with horseradish peroxidase (HRP)-conjugated secondary antibody (1:2000, Proteintech, USA) for 2 h at room temperature. The protein expression was visualized using ChemiDocTM XRS+ (Bio-Rad Laboratories, Inc., Hercules, CA, USA) with an enhanced chemiluminescence (ECL) kit (Millipore, Billerica, MA, USA). GAPDH was used as an internal control for normalization.

The fourth-passage PDLSCs from three donors were used for RNA sequencing after tension loading. Total RNA was extracted from the four groups of cells (normal PDLSCs and PDLSCs tensioned at frequencies of 0.1 Hz, 0.5 Hz, and 0.7 Hz for 6 h) using the Trizol (Sigma-Aldrich), according to the manufacturers protocols. After digestion with DNase, rRNA were depleted using a Ribo-Zero magnetic kit, and sequencing libraries were constructed as previously described.24 The sequencing of the cDNA library was carried out by Gene Denovo Biotechnology Co. (Guangzhou, China). The gene expression level was evaluated by reads per kilobase transcriptome per million mapped reads (RPKM). Requirements for filtering differentially expressed genes (DEGs) were as follows: (1) |log2 (fold-change)| 1; (2) p value < 0.05. DESeq2 (differential gene expression analysis based on the negative binomial distribution)25 was used to calculate p values and adjusted p (adj. p) values. Heatmaps and volcano plots analyses were used to visualize these DEGs using the Complex Heatmap package and ggplots2 package of R software. The online tool Venny 2.1 (http://bioinfogp.cnb.csic.es/tools/venny/index.html) was applied to identify the common DEGs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were used for annotation visualization and integrated discovery. Raw data of the performed RNA sequencing (RNA-seq) were recorded in the SRA database with the SRA accession: PRJNA665587.

Gene expression pattern analysis is used to cluster genes of similar expression patterns for multiple samples in a tensile frequency order. To examine the expression pattern of DEGs in different frequencies, the expression data of each sample (in the order of treatment) were normalized to 0, log2 (v1/v0), and log2 (v2/v0), and then clustered using the Short Time-series Expression Miner software (STEM).26 The parameters were set as follows: (1) maximum unit change in model profiles between frequency points was 1; (2) maximum output profiles number was 20 (similar profiles will be merged; and (3) minimum ratio of fold change of DEGs was no less than 2.0. The clustered profiles with p value < 0.05 were considered as significant profiles. Then, the DEGs in all profiles or in each profile were subjected to GO and KEGG pathway enrichment analysis. STRING (https://string-db.org/) was used for PPI network analysis. The DEGs were mapped onto the PPI network with a minimum interaction score of 0.4. Cytoscape v3.7.1 software was used to visualize the PPI network. Gene network clustering analysis was performed to identify the key PPI network modules, using the MCODE and cytoHuba app from the Cytoscape software suite. Adj. p value < 0.05 was set as the significance threshold.

Total RNA was extracted using Trizol (Sigma-Aldrich) according to the manufacturers protocols. Quantitative real-time PCR (RTqPCR) was performed in triplicate using the Power SYBR Green PCR Mastermix (Applied Biosystems, Foster City, CA, USA). Sequences of the primers used are shown in Table S1. The mean expression values were calculated relative to GAPDH, which was used as an internal control for normalization.

For differential gene expression analysis, a likelihood ratio test was used assuming an underlying zero-inflated negative binomial distribution.25,27 FDR-corrected p-values were calculated using the Benjamini-Hochberg procedure.28 K-means cluster method29 was used for frequency cluster expression pattern analysis by the STEM software. P and Q values of GO/KEGG functional analysis and frequency cluster analysis were calculated based on a hypergeometric distribution.30 Values of the relative protein and mRNA expression were expressed as mean SD within each group. One-way ANOVA followed by SNK post hoc tests was used in the Western blotting assay and RTqPCR assay. The significance threshold was set at 0.05.

Immunofluorescent staining revealed that the isolated cells were positive for CD146, vimentin, and STRO-1 (Figure 1AC, respectively) but negative for pan-cytokeratin (Figure 1D), confirming that the cells were mesenchymal stem cells of mesodermal origin. The osteogenic potential of PDLSCs was determined by positive ALP staining after 7 days of osteogenic induction (Figure 1E and F) and red mineralized matrix nodules in Alizarin Red staining after 14 days of osteogenic induction (Figure 1G and H). The presence of red lipid droplets in Oil Red staining after 21 days of adipogenic induction (Figure 1I) indicated the adipogenic differentiation of PDLSCs.

Figure 1 Identification of PDLSCs. The Immunofluorescence showed that the cells were positive for CD146 (A, red), vimentin (B, green), and STRO-1 (C, red) but negative for pan-cytokeratin (D). Scale bar = 50 m. ALP staining was positive both visually (E, black) and under the microscope (F, black, Scale bar = 100 m), after 7 days of osteogenesis induction culture. After 14 days of osteogenesis induction, ARS staining was observed to be positive by the naked eye (G, red), and mineralized nodules were obvious under the microscope (H, red, Scale bar = 100 m). After 21 days of adipogenic induction, oil red O-positive lipid clusters were observed microscopically (I, red, Scale bar = 100 m).

PDLSCs were exposed to 12% cyclic tension, which contributed to the cellular reorientation, including an irregular arrangement at the central region and a parallel arrangement at the peripheral region of the plate (Figure 2A). As shown in Figure 2B and C, after consecutive 10-h cyclic tensile force loading, the protein expression levels of Runx2 and COLI increased with increasing tensile frequency from 0.1 Hz to 0.7 Hz and were remarkably higher than that in the group without tension application (p < 0.05). The result suggested that mechanical tension (12% deformation) upregulated the osteogenesis of PDLSCs in a frequency-dependent manner. Higher frequencies of cyclic tension were associated with higher osteogenic differentiation of PDLSCs.

Figure 2 Cyclic tension promoted the osteogenic differentiation of PDLSCs. Under cyclic equibiaxial tension, PDLSCs reoriented in parallel alignment at the peripheral region of the plate, while in random orientation at the center of the plate (A, Scale bar = 100 m). Western blotting was used to detect protein levels of osteogenesis-related genes, COL-I and Runx2, at different tensile frequencies (B and C). **p < 0.01, ***p < 0.001, vs control group.

It has been previously shown that cyclic mechanical tensile stress can improve osteogenesis of PDLSCs, and that consecutive 46 h of tension can significantly upregulate the mRNA expression of osteogenesis-related genes.16,17 To gain insight into the molecular mechanisms by which mechanical tension stimulates osteoblast differentiation of PDLSCs, total RNA was extracted from PDLSCs to conduct RNA-seq after 6 h of cyclic tension. The mRNA expression profiles of the PDLSCs at different tensile frequencies (0.1 Hz, 0.5 Hz, and 0.7 Hz) were detected. Comparative expression analyses were performed according to the different frequencies of the tensile stress (0.1 Hz vs control, 0.5 Hz vs control, and 0.7 Hz vs control). Heat maps of the top 40 DEGs (Figure 3AC) and volcano plots (Figure 3DF) were depicted. In total, 50 mRNAs were upregulated, and 261 mRNAs were downregulated at 0.1 Hz. At 0.5 Hz, 656 mRNAs were upregulated, and 1474 mRNAs were downregulated. At 0.7Hz, 139 mRNAs were upregulated, and 194 mRNAs were downregulated. A Venny analysis (Figure 3G and H) showed that 78 genes were simultaneously upregulated and 118 were simultaneously downregulated among the 0.1 Hz, 0.5 Hz, and 0.7 Hz groups. The GO analysis (Figure 4A) demonstrated that changes in biological processes (BPs) were mainly enriched in metabolic process, response to stimulus, biological regulation, signaling, and localization. Changes in Cellular Components (CCs) were mainly enriched in organelle, membrane, macromolecular complex, and membrane-enclosed lumen. Moreover, binding, catalytic activity, and nucleic acid binding transcription factor activity emerged as the highest-ranked Molecular Function (MF) groups. As shown in Figure 4B, DNA replication, cell cycle, and the TNF signaling pathway were significantly enriched in the KEGG pathway. Within the primary category Environmental Information Processing, Signal transduction, and Signaling molecules and interaction were strongly enriched (Figure 4C).

Figure 3 Identification of DEGs among different frequencies. (AC) Heatmaps of the top 40 DEGs between 0.1 Hz/0.5 Hz/0.7 Hz and static culture, respectively. Red rectangles represent high expression, and blue rectangles represent low expression. (DF) Volcano plot of DEGs between 0.1 Hz/0.5 Hz/0.7 Hz and static culture, respectively. The red plots represent upregulated genes, the blue plots represent downregulated genes, and the black plots represent nonsignificant genes. (G) Venn diagram of upregulated DEGs among 0.1 Hz, 0.5 Hz, and 0.7 Hz. (H) Venn diagram of downregulated DEGs among all the three frequencies.

Figure 4 Functional enrichment analysis of all DEGs. (A) GO enrichment analysis of all DEGs among different frequencies. (B) Top 20 pathways of the KEGG enrichment analysis of all DEGs among different frequencies, with the KEGG pathway annotation (C). The screening criteria for significance were p value < 0.05.

The sequencing data were normalized to the control, and trend analyses of DEGs were identified using STEM. In Figure 5A, within the 20 model profiles, eight mRNA trend profiles were statistically significant. The profile number assigned by STEM was on the top left corner of each profile box, p value was on the bottom left, and the number of the cardinality of each cluster was on the top right corner. As shown in Table 1, among different profiles, the top-ranked KEGG pathways were mainly in the metabolic pathways, PI3K-Akt signaling pathway, cytokine-cytokine receptor interaction, and MAPK signaling pathway. A continuous downregulation pattern was found in profile 0 (Figure 5B), in which the high-ranked BPs, CCs, and MFs in GO enrichment (Figure 5C) were similar to those in Figure 4A, and inflammatory pathways such as arachidonic acid metabolism, peroxisome, and cytokinecytokine receptor interaction were strongly enriched (Figure 5D).

Table 1 Top 10 of KEGG Enrichment Among Different Profiles

Figure 5 Frequency series clustering analysis on expression profiles of mRNAs by STEM. (A) Within the 20 model profiles, eight mRNA trend profiles were statistically significant. The number at the upper-left corner of each profile box was the profile number assigned by STEM, the number on the bottom left was the p value, and the number on the top-right corner was the number of genes within each cluster. (B) Persistently downregulated genes along frequency were clustered in profile 0. (C) GO enrichment of profile 0. (D) Top 10 pathways of the KEGG enrichment of profile 0.

The interactions of 194 DEGs in profile 0 were analyzed using the STRING online database, and the PPI network was obtained using the Cytoscape software (Figure 6A). The MCODE plugin was then used to investigate the key PPI network modules, and one key module with four genes (EYA1, SIX5, SALL1, FRAS1) was identified (Figure 6B). The cytoHubba plugin was then used to analyze hub genes with maximum correlation criterion (MCC)/Degree, and genes with the top 10 scores were respectively identified. The intersection (EYA1, SALL1) of hub genes according to the above three methods were selected for further RTqPCR validation (Figure 6C). The results of RTqPCR (Figure 6D and E) showed that the mRNA expression of EYA1 and SALL1 decreased with increasing frequency from 0.1 Hz to 0.7 Hz, which were highly consistent with our high-throughput sequencing.

Figure 6 Identification and validation of mechanofreqency-sensitive hub genes. (A) The interaction network between proteins coded by the DEGs in profile 0. The nodes represent genes, and the edges represent links between genes. Blue represents downregulated genes. (B) The highest scoring module was extracted by MCODE. (C) The intersection was obtained among modules measured by MCODE, and the top 10 highly connected genes were identified using MCC and Degree in cytoHubba. (D and E) Validation of the expression of the two intersection genes, EYA1 and SALL1, using RTqPCR. *p < 0.05, vs control group.

OTM is based on remodeling processes in the periodontal ligament and the alveolar bone. PDLSCs play an important role in mechano-transduction and in promoting periodontal tissue regeneration in OTM.31,32 It is evident that cyclic tensile force regulates the osteogenic differentiation of PDLSCs.33 A complex network of signaling molecules regulates the osteoblastic differentiation of PDLSCs under cyclic tension.5,17,34 The heterogeneity of mechanical force parameters (duration, magnitude, frequency, and others)9 led to the heterogeneity of the osteogenic phenotype and gene regulation in different studies. This study focused on the effect of tensile frequency on the osteogenic differentiation of PDLSCs and attempted to elucidate a potential mechanism.

In the current study, we successfully isolated and characterized human PDSLCs. The cells at the 4th to 6th passage were used, whose phenotype was generally believed to be maintained.35 Mechanical tension was applied using the Flexcell tension system, which has been widely used in PDLSCs studies.2,20 We observed that the cellar reorientation after force loading was similar to that of the previous study,23 and this could be attributed to the mechano-responsive stress fibersfocal adhesion system.36 The present study showed that cyclic mechanical tension (magnitude: 12% deformation, duration: 10 h) in the range of 0.10.7 Hz promoted osteogenic marker genes including Runx2 and COL-I in PDLSCs, and their protein expressions increased with the increasing tensile frequency. Runx2 is an osteogenic lineage commitment specific transcription factor, which binds to the specific cis-acting elements of osteoblasts to promote the transcription and translation of OCN, osteopontin (OPN), bone sialoprotein (BSP), and COL-I.8 COL-I, which acts as a template onto which minerals are deposited to form bone matrix,37 is the major constituent of extracellular matrix in the periodontal ligament and bone, and is confirmed to be essential for osteogenesis in response to tension during OTM.38 Consistently, upregulation of RUNX2 and COL-I in response to tension was reported in most studies.9 To the best of our knowledge, the present study is the first to reveal the frequency dependence during cyclic tension in enhancing the expression of osteogenic markers within the first 10 h of cyclic tension application, which may inform a new method of accelerating OTM.

Using RNA-seq, we observed that mRNAs in strained PDLSCs were mainly enriched in response to the stimulus process, signal transduction, and relative pathways such as mismatch repair, TNF signaling pathway, and FOXO signaling pathway, which were associated with cell survival and differentiation as well as immune and inflammatory responses.39,40 The STEM platform was also used to investigate how gene expression profiles change with tensile frequency during the osteoblast differentiation of PDLSCs under cyclic tension. Eight trend profiles were noted as significant. Genes in these profiles were mainly enriched in the metabolic pathways, PI3K-Akt signaling pathway, cytokine-cytokine receptor interaction, and MAPK signaling pathway. The PI3K-Akt signaling pathway has been reported to be involved in the mechanical force-induced osteoblast differentiation of PDLSCs.41,42 The MAPK signaling pathway also have been found to participate in the mechano-transduction of PDLSCs.43,44

Genes in profile 0 showed a continuous downward trend from 0.1 Hz to 0.7 Hz, an inverse trend of osteogenic genes, and were mainly enriched for pathways related to an inflammatory response, such as arachidonic acid metabolism and cytokinecytokine receptor interaction. Cyclooxygenase-2 (COX2) and prostaglandin E synthase (PTGES) participate in the arachidonic acid metabolism pathway. TNF Receptor Superfamily Member 14 (TNFRSF14) and Interleukin 9 (IL9) are involved in the cytokinecytokine receptor interaction. PTGES is induced by inflammatory mediators.45 COX2 is involved in the synthesis of prostaglandin E2 (PGE2), which is a potent pro-inflammatory cytokine, and participates in bone resorption.2 The expression of COX2 and PGE2 after mechanical stimulation was previously reported to be correlated with force duration and force magnitude,9 and it showed a negative correlation with tensile frequency in the present study. TNFRSF14 is a membrane-bound receptor leading to the induction of proinflammatory genes by activating the NF-B pathway.46 IL-9 plays a role in regulating inflammatory immunity, and it has demonstrated pro-inflammatory activity in several mouse models of inflammation.47 The response of periodontal ligament to mechanical stress generated by OTM is known as an aseptic transitory inflammatory process, which is regulated by various cytokines and chemokines.48 Proinflammatory cytokines activate matrix metalloproteinases (MMPs), degrade the ECM, and inhibit the expression of COL-I.49 Increased osteogenesis is usually accompanied by lower levels of inflammatory cytokines and chemokines.10,50,51 Accordingly, in the present study, with increasing frequency, the osteogenic commitment increased, and the suppression of pro-inflammatory genes and the relative inflammatory response pathway were observed.

Furthermore, through PPI network screening, we identified two candidate genes, EYA1 and SALL1, which were specifically sensitized to tensile frequency. The result was validated by RTqPCR, which confirmed the decreased expression of EYA1 and SALL1 with increasing frequency of tension stimulation. EYA1 is a conserved critical regulator of organ-specific stem cells.52 SALL1 is also considered a stem cell marker.53 The osteoblastic differentiation of PDLSCs increased with increasing tensile frequency; thus, stemness and related genes correspondingly reduced. In view of the high-throughput sequencing and validation after 6 h of tensile force exposure, further studies over a longer period are needed. Whether overexpression of EYA1 and SALL1 would reverse the frequency-dependent trend of the osteogenic differentiation of PDLSCs also deserves further study.

In the present study, the role of tensile frequency on osteogenic commitment of PDLSCs were identified, and the mRNA transcriptomes of PDLSCs during the osteogenic differentiation under cyclic tension with different frequencies were delineated. Frequency series clustering were defined using STEM, and tensile frequency-sensitive genes were identified. This study extends the knowledge about the role of tensile frequency in cyclic tension induced PDLSCs osteogenesis.

The osteoblastic differentiation of PDLSCs under mechanical tensile force is frequency dependent. EYA1 and SALL1 were identified as potential important tensile frequency-sensitive genes, which may contribute to the cyclic tension-induced osteogenic differentiation of PDLSCs in a frequency-dependent manner.

Raw data of the performed RNA sequencing (RNA-seq) have been recorded in the SRA database with the SRA accession: PRJNA665587 (https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA665587). Other data in this study are available from the corresponding author Xi Chen upon request.

The study was performed in accordance with the principles stated in the Declaration of Helsinki and approved by the Medical Ethics Committee of the First Affiliated Hospital of Medical College of Xi an Jiaotong University (No: XJTU1AF2019LSK-078). Informed consent was obtained from all donors and their legal guardians involved in the study. Written informed consent was also obtained from the donors and their legal guardians to publish this paper.

All authors made a significant contribution to the work reported, whether in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

This research was funded by the Key Research and Development project of Shaanxi Province under Grant 2018SF-037.

The authors declare that they have no competing interests.

1. Wang H, Sun W, Ma J, Pan Y, Wang L, Zhang W. Polycystin-1 mediates mechanical strain-induced osteoblastic mechanoresponses via potentiation of intracellular calcium and Akt/-catenin pathway. PLoS One. 2014;9(3):e91730. doi:10.1371/journal.pone.0091730

2. Li M, Zhang C, Yang Y. Effects of mechanical forces on osteogenesis and osteoclastogenesis in human periodontal ligament fibroblasts: a systematic review of in vitro studies. Bone Joint Res. 2019;8(1):1931. doi:10.1302/2046-3758.81.Bjr-2018-0060.R1

3. Chang M, Lin H, Fu H, Wang B, Han G, Fan M. MicroRNA-195-5p regulates osteogenic differentiation of periodontal ligament cells under mechanical loading. J Cell Physiol. 2017;232(12):37623774. doi:10.1002/jcp.25856

4. Yang Y, Wang BK, Chang ML, Wan ZQ, Han GL. Cyclic stretch enhances osteogenic differentiation of human periodontal ligament cells via YAP activation. Biomed Res Int. 2018;2018:2174824. doi:10.1155/2018/2174824

5. Jin SS, He DQ, Wang Y, et al. Mechanical force modulates periodontal ligament stem cell characteristics during bone remodelling via TRPV4. Cell Prolif. 2020;53(10):e12912. doi:10.1111/cpr.12912

6. Katz S, Boland R, Santilln G. Modulation of ERK 1/2 and p38 MAPK signaling pathways by ATP in osteoblasts: involvement of mechanical stress-activated calcium influx, PKC and Src activation. Int J Biochem Cell Biol. 2006;38(12):20822091. doi:10.1016/j.biocel.2006.05.018

7. Ren D, Wei F, Hu L, Yang S, Wang C, Yuan X. Phosphorylation of Runx2, induced by cyclic mechanical tension via ERK1/2 pathway, contributes to osteodifferentiation of human periodontal ligament fibroblasts. J Cell Physiol. 2015;230(10):24262436. doi:10.1002/jcp.24972

8. Xu J, Li Z, Hou Y, Fang W. Potential mechanisms underlying the Runx2 induced osteogenesis of bone marrow mesenchymal stem cells. Am J Transl Res. 2015;7(12):25272535.

9. Sun C, Janjic Rankovic M, Folwaczny M, Otto S, Wichelhaus A, Baumert U. Effect of tension on human periodontal ligament cells: systematic review and network analysis. Front Bioeng Biotechnol. 2021;9:695053. doi:10.3389/fbioe.2021.695053

10. Sun C, Janjic Rankovic M, Folwaczny M, et al. Effect of different parameters of in vitro static tensile strain on human periodontal ligament cells simulating the tension side of orthodontic tooth movement. Int J Mol Sci. 2022;23(3). doi:10.3390/ijms23031525

11. Natali AN, Pavan PG, Scarpa C. Numerical analysis of tooth mobility: formulation of a non-linear constitutive law for the periodontal ligament. Dent Mater. 2004;20(7):623629. doi:10.1016/j.dental.2003.08.003

12. Pinkerton MN, Wescott DC, Gaffey BJ, Beggs KT, Milne TJ, Meikle MC. Cultured human periodontal ligament cells constitutively express multiple osteotropic cytokines and growth factors, several of which are responsive to mechanical deformation. J Periodontal Res. 2008;43(3):343351. doi:10.1111/j.1600-0765.2007.01040.x

13. Liu J, Li Q, Liu S, et al. Periodontal ligament stem cells in the periodontitis microenvironment are sensitive to static mechanical strain. Stem Cells Int. 2017;2017:1380851. doi:10.1155/2017/1380851

14. Tang N, Zhao Z, Zhang L, et al. Up-regulated osteogenic transcription factors during early response of human periodontal ligament stem cells to cyclic tensile strain. Arch Med Sci. 2012;8(3):422430. doi:10.5114/aoms.2012.28810

15. Tantilertanant Y, Niyompanich J, Everts V, Supaphol P, Pavasant P, Sanchavanakit N. Cyclic tensile force stimulates BMP9 synthesis and in vitro mineralization by human periodontal ligament cells. J Cell Physiol. 2019;234(4):45284539. doi:10.1002/jcp.27257

16. Shen T, Qiu L, Chang H, et al. Cyclic tension promotes osteogenic differentiation in human periodontal ligament stem cells. Int J Clin Exp Pathol. 2014;7(11):78727880.

17. Wu X, Li Y, Cao Z, Xie Y, Fu C, Chen H. Mechanism of cyclic tensile stress in osteogenic differentiation of human periodontal ligament stem cells. Calcif Tissue Int. 2021;108(5):640653. doi:10.1007/s00223-020-00789-x

18. Wang Y, Hu B, Hu R, et al. TAZ contributes to osteogenic differentiation of periodontal ligament cells under tensile stress. J Periodontal Res. 2020;55(1):152160. doi:10.1111/jre.12698

19. Wang H, Feng C, Li M, Zhang Z, Liu J, Wei F. Analysis of lncRNAs-miRNAs-mRNAs networks in periodontal ligament stem cells under mechanical force. Oral Dis. 2021;27(2):325337. doi:10.1111/odi.13530

20. Yang L, Yang Y, Wang S, Li Y, Zhao Z. In vitro mechanical loading models for periodontal ligament cells: from two-dimensional to three-dimensional models. Arch Oral Biol. 2015;60(3):416424. doi:10.1016/j.archoralbio.2014.11.012

21. Hsieh YF, Turner CH. Effects of loading frequency on mechanically induced bone formation. J Bone Miner Res. 2001;16(5):918924. doi:10.1359/jbmr.2001.16.5.918

22. Scheuren AC, Vallaster P, Kuhn GA, et al. Mechano-regulation of trabecular bone adaptation is controlled by the local in vivo environment and logarithmically dependent on loading frequency. Front Bioeng Biotechnol. 2020;8:566346. doi:10.3389/fbioe.2020.566346

23. Yang SY, Wei FL, Hu LH, Wang CL. PERK-eIF2-ATF4 pathway mediated by endoplasmic reticulum stress response is involved in osteodifferentiation of human periodontal ligament cells under cyclic mechanical force. Cell Signal. 2016;28(8):880886. doi:10.1016/j.cellsig.2016.04.003

24. Borodina T, Adjaye J, Sultan M. A strand-specific library preparation protocol for RNA sequencing. Methods Enzymol. 2011;500:7998. doi:10.1016/b978-0-12-385118-5.00005-0

25. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8

26. Ernst J, Bar-Joseph Z. STEM: a tool for the analysis of short time series gene expression data. BMC Bioinform. 2006;7:191. doi:10.1186/1471-2105-7-191

27. Brulois K, Rajaraman A, Szade A, et al. A molecular map of murine lymph node blood vascular endothelium at single cell resolution. Nat Commun. 2020;11(1):3798. doi:10.1038/s41467-020-17291-5

28. Stanton BZ, Hodges C, Calarco JP, et al. Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin. Nat Genet. 2017;49(2):282288. doi:10.1038/ng.3735

29. Beauchaine TP, Beauchaine RJ. A comparison of maximum covariance and K-means cluster analysis in classifying cases into known taxon groups. Psychol Methods. 2002;7(2):245261. doi:10.1037/1082-989x.7.2.245

30. Iacono G, Dubos A, Mziane H, et al. Increased H3K9 methylation and impaired expression of Protocadherins are associated with the cognitive dysfunctions of the Kleefstra syndrome. Nucleic Acids Res. 2018;46(10):49504965. doi:10.1093/nar/gky196

31. Tantilertanant Y, Niyompanich J, Everts V, Supaphol P, Pavasant P, Sanchavanakit N. Cyclic tensile force-upregulated IL6 increases MMP3 expression by human periodontal ligament cells. Arch Oral Biol. 2019;107:104495. doi:10.1016/j.archoralbio.2019.104495

32. Symmank J, Zimmermann S, Goldschmitt J, et al. Mechanically-induced GDF15 secretion by periodontal ligament fibroblasts regulates osteogenic transcription. Sci Rep. 2019;9(1):11516. doi:10.1038/s41598-019-47639-x

33. Yu N, Prodanov L, Te Riet J, et al. Regulation of periodontal ligament cell behavior by cyclic mechanical loading and substrate nanotexture. J Periodontol. 2013;84(10):15041513. doi:10.1902/jop.2012.120513

34. Wei FL, Wang JH, Ding G, et al. Mechanical force-induced specific MicroRNA expression in human periodontal ligament stem cells. Cells Tissues Organs. 2014;199(56):353363. doi:10.1159/000369613

35. Jnsson D, Nebel D, Bratthall G, Nilsson BO. The human periodontal ligament cell: a fibroblast-like cell acting as an immune cell. J Periodontal Res. 2011;46(2):153157. doi:10.1111/j.1600-0765.2010.01331.x

36. Livne A, Bouchbinder E, Geiger B. Cell reorientation under cyclic stretching. Nat Commun. 2014;5:3938. doi:10.1038/ncomms4938

37. Rather HA, Jhala D, Vasita R. Dual functional approaches for osteogenesis coupled angiogenesis in bone tissue engineering. Mater Sci Eng C Mater Biol Appl. 2019;103:109761. doi:10.1016/j.msec.2019.109761

38. Jacobs C, Grimm S, Ziebart T, Walter C, Wehrbein H. Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain. Arch Oral Biol. 2013;58(7):896904. doi:10.1016/j.archoralbio.2013.01.009

39. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296(5573):16341635. doi:10.1126/science.1071924

40. Arden KC. FoxO: linking new signaling pathways. Mol Cell. 2004;14(4):416418. doi:10.1016/s1097-2765(04)00213-8

41. Qi L, Zhang Y. The microRNA 132 regulates fluid shear stress-induced differentiation in periodontal ligament cells through mTOR signaling pathway. Cell Physiol Biochem. 2014;33(2):433445. doi:10.1159/000358624

42. Jiang N, He D, Ma Y, et al. Force-induced autophagy in periodontal ligament stem cells modulates M1 macrophage polarization via AKT signaling. Front Cell Dev Biol. 2021;9:666631. doi:10.3389/fcell.2021.666631

43. Ziegler N, Alonso A, Steinberg T, et al. Mechano-transduction in periodontal ligament cells identifies activated states of MAP-kinases p42/44 and p38-stress kinase as a mechanism for MMP-13 expression. BMC Cell Biol. 2010;11:10. doi:10.1186/1471-2121-11-10

44. Tang M, Peng Z, Mai Z, et al. Fluid shear stress stimulates osteogenic differentiation of human periodontal ligament cells via the extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling pathways. J Periodontol. 2014;85(12):18061813. doi:10.1902/jop.2014.140244

45. Blair PJ, Hwang SJ, Shonnard MC, et al. The role of prostaglandins in disrupted gastric motor activity associated with type 2 diabetes. Diabetes. 2019;68(3):637647. doi:10.2337/db18-1064

46. Shui JW, Steinberg MW, Kronenberg M. Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling. J Leukoc Biol. 2011;89(4):517523. doi:10.1189/jlb.0910528

47. Goswami R, Kaplan MH. A brief history of IL-9. J Immunol. 2011;186(6):32833288. doi:10.4049/jimmunol.1003049

48. Lee SI, Park KH, Kim SJ, Kang YG, Lee YM, Kim EC. Mechanical stress-activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells. Clin Exp Immunol. 2012;168(1):113124. doi:10.1111/j.1365-2249.2011.04549.x

49. Sun C, Liu F, Cen S, et al. Tensile strength suppresses the osteogenesis of periodontal ligament cells in inflammatory microenvironments. Mol Med Rep. 2017;16(1):666672. doi:10.3892/mmr.2017.6644

50. Loi F, Crdova LA, Pajarinen J, Lin TH, Yao Z, Goodman SB. Inflammation, fracture and bone repair. Bone. 2016;86:119130. doi:10.1016/j.bone.2016.02.020

51. Orapiriyakul W, Tsimbouri MP, Childs P, et al. Nanovibrational stimulation of mesenchymal stem cells induces therapeutic reactive oxygen species and inflammation for three-dimensional bone tissue engineering. ACS Nano. 2020;14(8):1002710044. doi:10.1021/acsnano.0c03130

52. Sun Y, Kaneko S, Li XK, The LX. PI3K/Akt signal hyperactivates Eya1 via the SUMOylation pathway. Oncogene. 2015;34(19):25272537. doi:10.1038/onc.2014.179

53. Griesche N, Luttmann W, Luttmann A, Stammermann T, Geiger H, Baer PC. A simple modification of the separation method reduces heterogeneity of adipose-derived stem cells. Cells Tissues Organs. 2010;192(2):106115. doi:10.1159/000289586

Read more:
Effect of tensile frequency on osteogenic differentiation | IJGM - Dove Medical Press

Posted in Utah Stem Cells | Comments Off on Effect of tensile frequency on osteogenic differentiation | IJGM – Dove Medical Press

Paolo Macchiarini – Wikipedia

Posted: July 3, 2022 at 2:25 am

Swiss-born Italian physician

Paolo Macchiarini (born 22 August 1958)[1]:2 is a Swiss-born Italian thoracic surgeon and former regenerative medicine researcher who became known for research fraud and manipulative behavior.[2][3]

Previously considered a pioneer for using both biological and synthetic scaffolds seeded with patients' own stem cells as trachea transplants, Macchiarini was a Visiting Professor and Director on a temporary contract at Sweden's Karolinska Institutet (KI) from 2010.[4] Macchiarini has been accused of unethically performing experimental surgeries, even on relatively healthy patients, resulting in fatalities for seven of the eight patients who received one of his synthetic trachea transplants.[5] Articles in Vanity Fair and Aftonbladet further suggested that he had falsified some of his academic credentials on rsums.[6][7]

Urban Lendahl[sv], the secretary of the Nobel Committee for Physiology or Medicine, resigned in February 2016, owing to his involvement in recruiting Macchiarini to KI.[8]Shortly afterwards KI's vice chancellor, Anders Hamsten[sv], who in 2015 had cleared Macchiarini of misconduct, also resigned.[9] KI terminated its clinical relationship with Macchiarini in 2013 but allowed him to continue as a researcher; in February 2016, the university announced that it would not renew his research contract, which was due to expire in November, and terminated the contract the following month.[10] After being dismissed from KI, Macchiarini worked at the Kazan Federal University in Russia until that institution terminated his project in April 2017, effectively firing him.[11][12]

After a one-year medico-legal investigation, the Swedish Prosecution Authority announced in October 2017 that Macchiarini had been negligent in four of the five cases investigated due to the use of devices and procedures not supported by evidence, but that a crime could not be proven because the patients might have died under any other treatment given.[13][14] Also in October, Sweden's Expert Group on Scientific Misconduct found evidence of research fraud by Macchiarini and his co-authors in six papers and called for them to be retracted.[15] As of 2020, Macchiarini has had eight of his research papers retracted, and two have received an expression of concern.[16]

Paolo Macchiarini obtained his medical degree (equivalent to MD) at the Medical School of the University of Pisa (UniPi) in 1986 and a Master of Surgery in 1991.[17] He was an assistant professor at UniPi from 1990 to 1992.[17] He took a course on statistics in clinical research at University of Alabama at Birmingham in 1989.[17] Macchiarini obtained degree certificatesa masters in organ and tissue transplantation dated 1994 and a doctorate in the same dated 1997from University of Franche-Comt in France.[17] According to Germany's Hannover Medical School, he never had a salaried position there, but was head of the department of thoracic and vascular surgery at the Heidehaus Hanover hospital between 1999 and 2004.[17] Macchiarini was an investigator at the Institut d'Investigacions Biomdiques-Instituto de Investigaciones Biomdicas in Barcelona, Spain, from 2006 to 2009; he was affiliated with but not an employee of the University of Barcelona and was apparently an employee at the Hospital Clnic de Barcelona during this time.[17] He had an honorary appointment as a Visiting Professor from 2009 to 2014, at University College London.[17] He was a consultant and project manager at University Hospital Careggi (AOUC) starting in 2010.[17]

Later in 2010, Macchiarini was appointed as a visiting professor at the Karolinska Institute (KI) in Stockholm and as a part-time position as surgeon at the affiliated university hospital.[17] In 2013, KI terminated its clinical relationship with Macchiarini but allowed him to continue as a researcher; in February 2016, the university announced that it would not renew Macchiarini's research contract, which was due to expire in November, and terminated the contract the following month.[10][18] KI published the incomplete results of its verification of Macchiarini's CV in February 2016.[17]

Macchiarini made ties in Russia after he gave a master class in 2010, at the invitation of politician Mikhail Batin; a few months later he did a trachea transplant there which was widely covered in Russian media.[12] This led to Macchiarini's 2011 appointment at Kuban State Medical University, funded by the university and the Russian government,[12] along with an honorary doctorate.[17] In 2016, he moved to Kazan Federal University and the grant money moved with him.[12] In April 2017, the university terminated Macchiarini's research project there.[12]

In June 2008, Macchiarini conducted a transplant of a donated trachea colonized with the stem cells of the recipient, Claudia Castillo; the tissue was used to replace her left bronchus, which had been damaged by tuberculosis, and her left lung had collapsed.[19] The trachea came from a cadaver, and was stripped of its cells and seeded with cells taken from Castillo's bone marrow.[19][20][21] The bone marrow cells were cultured at the University of Bristol, the donor trachea was stripped at University of Padua, the stripped trachea was seeded with the cultured cells at University of Milan, and the trachea was transplanted by a team led by Macchiarini at Hospital Clinic in Barcelona.[19][22]

In March 2010, Macchiarini attended a transplant performed by Great Ormond Street surgeons. Similar to the one done for Castillo, on a ten-year-old Irish boy, Ciaran Finn-Lynch, at Great Ormond Street Hospital in London.[23] The boy was born with a 1mm diameter trachea, and efforts to widen it had caused life-threatening complications.[23] Unlike the Castillo procedure, in this case, the stripped trachea was seeded with the boy's stem cells just hours before it was implanted.

Keziah Shorten had trachea cancer. In 2010, Macchiarini performed a transplant similar to the earlier two; the transplant failed the next year, and a synthetic trachea was implanted for palliative care at University College Hospital London in 2011, after which she was able to be discharged and return home for Christmas with her family before succumbing to her underlying disease.[24]

In 2010, Macchiarini implanted a seeded donated trachea in a woman in Russia, while working with surgeon Vladimir Parshin.[12][25][26]

Andemariam Teklesenbet Beyene was a man from Eritrea who was earning a master's degree in Iceland when he was diagnosed with cancer; the cancer was treated with chemotherapy and surgery in 2009, but in 2011 his trachea was obstructed again. Beyene's doctors recommended palliative care, but also reached out to Macchiarini, who was at KI by that time.[27]:8 In this case, Macchiarini collaborated with scientists at University College London to manufacture a fully synthetic trachea, with an engineered scaffold seeded with Beyene's marrow cells, instead of using a donated and stripped trachea, as it had been done before.[24] The operation occurred in June 2011 and was widely covered in the media, including a front page story in The New York Times.[28] By end of the year the implant was failing, and while Beyene was able to complete his Ph.D in 2012, he died in January 2013 despite undergoing many treatments at KI.[27]:8 The autopsy showed that Beyene had a chronic lung infection, a clot in his lung, and the synthetic trachea had come loose.[27]:8

Christopher Lyles lived in the United States; he had tracheal cancer which was treated with radiation and surgery. He heard about Beyene's treatment and through his doctor asked Macchiarini to do the same for him. Macchiarini obliged, creating a fully synthetic trachea seeded with stem cells from Lyles and implanting it at KI in November 2011.[27]:9 Lyles died suddenly in 2012 after he had returned home; no autopsy was performed.[27]:9[29]

In June 2012, Macchiarini implanted a fully synthetic seeded trachea in Yulia Tuulik at Kuban State Medical University; Tuulik had a tracheostomy resulting from a car accident, but her life was not in danger.[12][30] The graft included a cricoid cartilage, part of the voice box, which Macchiarini had not tried before.[30] The trachea later collapsed, and was replaced; she died in 2014.[12] An audit by the Russian government later found that Macchiarini had operated without a Russian medical license.[12]

Also in June 2012, Macchiarini implanted a second synthetic seeded trachea on Alexander Zozulya, who also had a tracheostomy resulting from a car accident and whose life was not in danger.[12][24][30] The effects from the first implant in 2012 prompted a second surgery in November 2013. Zozulya died in February 2014 under unclear circumstances.[24]

Turkish national Yesim Cetir underwent a routine surgery in 2011 to treat excessive sweating in her hands, but due to an error her trachea was severely injured and her left lung was damaged.[24][27]:9 She came to Macchiarini at the KI for treatment, and in 2012 he first removed her left lung and replaced her trachea with a pipe, then replaced the pipe with a fully synthetic seeded trachea.[27]:9 The next year the implant collapsed and Macchiarini replaced it with a second one.[27]:9 Cetir had many complications from this procedure, remained in constant need of having her airway cleared, and suffered kidney failure.[27]:9 In 2016 she underwent multiple organ transplants in the U.S., and her trachea was replaced with one from a cadaver.[27]:9 Cetir died in March 2017.[31]

In April 2013, Macchiarini implanted a fully synthetic seeded trachea in two-year-old Hannah Warren, who had been born without one.[32] The operation was performed at OSF Saint Francis Medical Center in Peoria, Illinois, United States.[32] The operation also involved her esophagus, which didn't heal properly and required a second operation in June; she died 6 July 2013, from complications of the second surgery.[33]

In August 2013 Sadiq Kanaan received a fully synthetic seeded tracheal implant from Macchiarini at Kuban State Medical University.[11][24] He died later the same year.[11]

In June 2014, Macchiarini implanted a fully synthetic seeded trachea in Dmitri Onogda at the Kuban State Medical University.[11][24] The implant failed and was replaced, and as of 2017 Onogda was still alive.[11][24]

In 2012, Macchiarini was arrested in Italy and charged with asking patients at AOUC for money to expedite their procedures;[34] the charges were dismissed in May 2015[35] and the prosecutor's appeal was dismissed in September 2015.[36]

In 2014, Macchiarini was accused by four former colleagues and co-authors of having falsified claims in his research with KI.[37] The following April, KI's ethics committee issued a response to one set of allegations with regard to research ethics and peer review at The Lancet, and found them to be groundless.[38]

KI had also appointed an external expert, Bengt Gerdin, to review the charges, comparing the results reported to the medical record of the hospital; the report was released by the university in May 2015.[39][40][41] Gerdin found that Macchiarini had committed research misconduct in seven papers by not getting ethical approval for the some of his operations, and misrepresenting the result of some of those operations, as well as work he had done in animals.[39][40][42]

In August 2015, after considering the findings and a rebuttal provided by Macchiarini, KI vice-chancellor Anders Hamsten found that he had acted "without due care" but had not committed misconduct.[43][44] The Lancet, which published Macchiarini's work, also published an article defending him.[45]

On 13 January 2016, Gerdin criticized the vice-chancellor's dismissal of the allegations in an interview with Sveriges Television (SVT).[46] Later that day, the SVT investigative program Dokument inifrn began broadcasting a three-part series, titled "Experimenten", in which Macchiarini's work was investigated.[47][48] The documentary shows Macchiarini continuing operations with his new transplant method even after it showed little or no promise, exaggerating the health of his patients in articles as they died. While Macchiarini admitted that the synthetic trachea did not work in the current state, he did not agree that trying it on several additional patients without further testing had been inappropriate. Allegations were also made that patients' medical conditions both before and after the operations, as reported in academic papers, did not match reality. Macchiarini also stated that the synthetic trachea had been tested on animals before using it on humans, something that could not be verified.[10][18][24]

On 28 January, KI issued a statement saying that the documentary made claims of which it was unaware, and that it would consider re-opening the investigations.[49][50] These concerns were echoed by KI's chairman, Lars Leijonborg, and the chairman of the Swedish Medical Association, Heidi Stensmyren, calling for an independent investigation that would also look at how the issue was dealt with by the university and hospital management.[51]

In February 2016, KI published a review of Macchiarini's CV that identified discrepancies.[17] The university announced that it would not renew Macchiarini's research contract, which was due to expire in November, and the next month Karolinska terminated the contract.[10]

In October 2016, the BBC broadcast a three-part Storyville documentary, Fatal Experiments: The Downfall of a Supersurgeon, directed by Bosse Lindquist and based on the earlier Swedish programmes about Macchiarini.[52] After the special aired, KI requested Sweden's national scientific review board to review six of Macchiarini's publications about the procedures. The board published its findings in October 2017, and concluded that all six were the result of scientific misconduct, in particular by failing to report the complications and deaths that occurred after the interventions; one of the articles also claimed that the procedure had been approved by an ethics committee, when this had not happened. The board called for all six of the papers to be retracted. It also said that all of the co-authors had committed scientific misconduct as well.[15]

The following papers authored by Macchiarini have been retracted:

A story published by Vanity Fair on 5 January 2016 discussed Macchiarini's affair with a journalist, who had written enthusiastic articles about him. The story also called into question statements he had made on his CV.[47][6] The article paints him as a serial fabulist, and as "the extreme form of a con man," remarking that "the fact that he could keep all the details straight and compartmentalize these different lives and lies is really amazing."[6] The article details a courtship and alleged subsequent marriage arrangements from the perspective of a NBC News producer, Benita Alexander. Alexander had been tasked by NBC News to produce a documentary-type programme for Dateline in 2013 called "A Leap of Faith" to portray Macchiarini and she ultimately began an affair with her subject, only to find out later in 2015 that he had been married for thirty years, including the entire period of the courtship. The details recounted in the article include Alexander relating Macchiarini's alleged lies about being a surgeon to the stars and current and former heads of state, and a planned wedding to Alexander to be the social event of the year (with Pope Francis officiating, Andrea Bocelli singing, Enoteca Pinchiorri catering, and numerous celebrities attending), among other reported falsified details about his C.V. and personal life.[6]

Macchiarini is reported to have claimed that Pope Francis had given his personal blessing for the wedding between the couple, both said to be divorcees, and would host the ceremony. The Pope's spokesman said that the Pope had no "personal doctor" named Macchiarini, knew nobody of that name, and would not have officiated.[60]

In August 2021, the third season of the Dr. Death podcast began publishing episodes consisting a six-episode season about Macchiarini, entitled "Miracle Man". The audio series covers the accusations of ethical misconduct and manipulation in Macchiarini's medical work alongside those of his personal deceit in his affair with Alexander, told through a series of interviews with the latter.[61]

The secretary of the Nobel Committee for Physiology or Medicine, Urban Lendahl, resigned in February 2016, owing to his involvement in recruiting Macchiarini to Karolinska Institutet in 2010.[8][62] Shortly afterwards the vice chancellor, Anders Hamsten, who in 2015 had cleared Macchiarini of scientific misconduct, also resigned.[9][63]

In August 2016, a committee led by Kjell Asplund that had been called into being in February to investigate the three operations that Macchiarini had performed at the Karolinska University Hospital issued its report, identifying several ethical shortcomings by the hospital and Macchiarini; it also noted the pressure put on the hospital by the institute with regard to Macchiarini's hospital appointment and translational research.[27][64]

Another report was issued in early September that examined the behavior of the institute; it was authored by a committee led by Sten Heckscher. The report found that the institute had conducted almost no diligence in hiring Macchiarini nor in overseeing his work, nor in considering his performance in reviewing his contracts; the committee found that interference from people higher up in management had interfered in the processes.[64][65][66]

On 5 September 2016, the Swedish government moved to dismiss the entire board of the Institute.[67] Shortly afterwards Harriet Wallberg and Anders Hamsten were removed from the judging panel that is responsible for annually choosing the Nobel Prize for Medicine, selection of which is additionally overseen by Karolinska Institutet.[68]

In June 2016 Swedish police opened an investigation into whether Macchiarini might have committed involuntary manslaughter.[11][24] In October 2017, the public prosecutor office announced that all criminal charges against Macchiarini have been dropped, although the medical treatment in four of five cases operated in Sweden was classified as 'negligent' the criminal responsibility cannot be proven.[69] After a one-year medico-legal investigation, the attorney general's office announced in October 2017 that Macchiarini had been negligent in four of the five cases investigated due to the use of devices and procedures not supported by evidence, but that a crime could not be proven because the patients might have died under any other treatment given.[13][14]

In 2019, an Italian court sentenced Macchiarini to sixteen months in prison for abuse of office and forging documents.[70]

On 29 September 2020, Mikael Bjork, director of Public Prosecution in Sweden indicted an unnamed surgeon on charges of aggravated assault. Swedish news agency TT said the indicted surgeon was Dr. Paolo Macchiarini. Bjork said he reopened the investigation in December 2018 and obtained new written evidence and interviewed individuals in five different countries. Bjork said victims received "serious physical injuries and great suffering" as a result of the operations performed on them and that he "made the assessment that the three operations are therefore to be considered as aggravated assault."[70] The trial against Paolo Macchiarini ended on 23 May 2022, and he was found guilty to having caused bodily harm, but not assault. He was received a probationary sentence on 16 June 2022.[71][72]

Here is the original post:
Paolo Macchiarini - Wikipedia

Posted in Alabama Stem Cells | Comments Off on Paolo Macchiarini – Wikipedia

President Freeman Hrabowski prepares for retirement after turning UMBC into the top producer of Black M.D., Ph.D. graduates – Afro American

Posted: July 3, 2022 at 2:25 am

By Megan Sayles, AFRO Business Writer, Report for America Corps Member, msayles@afro.com

President Freeman Hrabowski III has led the University of Maryland, Baltimore County (UMBC), since 1992. After decades of revolutionary leadership, the giant of higher education announced his retirement.

In spite of his profound adoration for the school and its students, Hrabowski is ready for his next chapter in which he will mentor new presidents and provosts at Harvard University. He will also support the Howard Hughes Medical Institutes novel, billion-dollar program to produce more scientists of color.

The program was named after Hrabowski, a privilege he deemed inconceivable.

For a Black kid who went to jail with Dr. King and didnt know what was going to happen, this is an honor I could have never imagined, said Hrabowski.

Born in Birmingham, Ala., Hrabowski grew up in a middle-class family. His parents were teachers, meaning he grew up as privileged as a Black kid could be during the 1950s and 60s in the Deep South.

Living separate but equal, he couldnt go through certain doors, eat-in certain restaurants, or drink out of certain water fountains, but his parents time and time again instructed him to never let anyone else define who he was.

When Hrabowski was 12 years old, he marched in the Birmingham Childrens Crusade. He along with thousands of other youth were taken to jail for their efforts to protest against segregation.

During his week in jail, Hrabowski looked out his cells window and wondered, will I be OK? The experience was a turning point for him.

Hrabowski became the poster child for the Civil Rights Movement in Birmingham, giving speeches in churches, NAACP meetings, Alabama Christian Movement meetings, and to Black sororities and fraternities.

While his dedication to civil rights never ceased, Hrabowski had another passion: mathematics.

He was a gifted student and dreamed of becoming a math teacher one day because doing arithmetic gave him goosebumps.

His parents were proud graduates of Tuskegee University, and Hrabowski spent much of his time at the campus, which showed him how nurturing historically Black colleges and universities (HBCUs) are.

He knew he had to attend an HBCU after taking summer courses in Massachusetts. There, Hrabowski was the invisible man. His fellow students ignored him, and his teachers refused to speak to him.

At age 15, he attended Hampton University, in spite of his parents desire for him to enroll at Morehouse College, and he completed his undergraduate degree in mathematics at 18. He also met Jacqueline Coleman at the university. She has been his wife for 50 years.

Ever since he was young, Hrabowski wanted to earn a Ph.D., so after graduating from Hampton University, he attended the University of Illinois Urbana-Champaign where he received his masters in mathematics and then his doctorate in higher education administration.

At 26, Hrabowski became the dean of arts and sciences at Coppin State University and achieved his dream of teaching mathematics. He remained at the school for a decade and exited as vice president of academic affairs when former UMBC (University of Maryland, Baltimore County) President, Michael Hooker, offered him the opportunity to become the next provost.

Hrabowski was no stranger to the university, as his wife taught early childhood education and child psychology there. His first impression of the campus was that it was suburban, young and boasted an abundance of bright students.

After several years of serving as provost, he became president of the predominantly White institution.

Hrabowskis tenure as president can be distinguished by its emphasis on science, technology, engineering, and mathematics (STEM) education.

When he took office, UMBC students who studied the STEM disciplines, struggled to attain their degrees, and Black students faced even more challenges than their White counterparts.

He made it his mission to ensure all UMBC students have the ability to succeed in STEM.

Today, UMBC is a Research One (R1) university, the nations highest level of research performance. The school also graduates more Black students who go on to earn doctoral degrees in natural sciences and engineering than any other U.S. college. It is also the number one institution to produce Black graduates who go on to earn M.D. and Ph.D.s.

The Black graduation rates are as higher than any other institution, and half of our Black students are male, which is unheard of in American education, said Hrabowski.

His most cherished memories of UMBC involve witnessing former retrievers, the universitys mascot, excel in their careers.

Most notably, UMBC is credited for having the first Black woman to create a vaccine, Kissmekia Corbett. She was a student in the Meyerhoff Scholars Program, which was designed to prepare minority students for STEM disciplines, and graduated from the university in 2008.

During the COVID-19 pandemic, she played an instrumental role in the development of the Moderna vaccine.

Hrabowski said he hopes hes left a legacy at UMBC that students of all races can excel.

Valerie Sheares Ashby will become the universitys next president, the first woman to hold the position, and Hrabowski has no doubt that she will continue to propel the university forward.

Help us Continue to tell OUR Story and join the AFRO family as a member subscribers are now members! Joinhere!

Read more here:
President Freeman Hrabowski prepares for retirement after turning UMBC into the top producer of Black M.D., Ph.D. graduates - Afro American

Posted in Alabama Stem Cells | Comments Off on President Freeman Hrabowski prepares for retirement after turning UMBC into the top producer of Black M.D., Ph.D. graduates – Afro American

Haifan Lin takes on new role as President of the ISSCR – EurekAlert

Posted: July 3, 2022 at 2:23 am

image:Haifan Lin assumes the role of ISSCR president. view more

Credit: Yale University School of Medicine, USA

TheISSCR is pleased to announce Haifan Lin, PhD, Yale University School of Medicine, USA, as its President. Dr. Lins one-year term of office leading the global Society begins today.

It is a great honor for me to assume the ISSCR presidency during the 20th anniversary year of the Societys founding, Dr. Lin said. In the past 20 years, the ISSCR has embodied our shared passion for stem cell research. The remarkable growth of the Society is driven by our members exciting research and discoveries, many of which are being translated into lifesaving treatments and new approaches in drug development for the benefit of humanity.

Dr. Lin urged, In a time challenged by the persisting pandemic as well as by polarizing geopolitical forces and a devastating war, there is more need and more urgency for ISSCR to serve as a haven for stem cell researchers from all over the world to work together synergistically for the benefit of all mankind, regardless of race, color, religion, gender, and national origin. He pledged, to work closely with members, the board, and the staff to actively expend our global engagement in both academia and industry during my presidency.

Haifan Lin is the Eugene Higgins Professor of Cell Biology and founding Director of Yale Stem Cell Center at Yale University School of Medicine, a Member of US National Academy of Sciences, a Member of American Academy of Arts and Sciences, and a Foreign Member of Chinese Academy of Sciences.

Dr. Lin studies the self-renewing mechanism of stem cells, stem cell-related cancers, and germline development, using Drosophila germline stem cells, mouse germline and embryonic stem cells, Hydra stem cells, and human cancer cells as models. He has made key contributions to the demonstration of stem cell asymmetric division and the proof of the stem cell niche theory. He discovered the Argonaute/Piwi gene family and their essential function in stem cell self-renewal and germline development and demonstrated their crucial function in breast and colon cancers. He is a discoverer of PIWI-interacting RNAs (piRNAs), a discovery hailed by the Science magazine as one of the 10 Scientific Breakthroughs in 2006. Recently, he proposed and demonstrated the crucial roles of the Piwi-piRNA pathway in epigenetic programming and in post-transcriptional regulation of mRNA and lncRNA.

Amander T. Clark, PhD, University of California, Los Angeles, USA is President-Elect and will serve as President in 2023. Valentina Greco, PhD, Yale Stem Cell Center, USA is the new Vice President and Clive Svendsen, PhD, Cedars-Sinai Regenerative Medicine Institute, USA, is the Societys new Treasurer.

Helen Blau, PhD, Stanford University School of Medicine, USA, and Kathy Niakan, PhD, University of Cambridge, UK were elected as new Board Members and begin their three-year terms 1 July 2022. Arnold Kriegstein, MD, PhD, University of California, San Francisco, USA and Kenneth Zaret, PhD, University of Pennsylvania School of Medicine, USA were re-appointed to another term.

Learn more.

About the International Society for Stem Cell Research (www.isscr.org)With more than 4,400 members from more than 70 countries, the International Society for Stem Cell Research is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health. Additional information about stem cell science is available at A Closer Look at Stem Cells, an initiative of the Society to inform the public about stem cell research and its potential to improve human health.

###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

See the rest here:
Haifan Lin takes on new role as President of the ISSCR - EurekAlert

Posted in California Stem Cells | Comments Off on Haifan Lin takes on new role as President of the ISSCR – EurekAlert

UCI-led team discovers signaling molecule that potently stimulates hair growth – UCI News

Posted: July 3, 2022 at 2:23 am

Irvine, Calif., June 30, 2022 University of California, Irvine-led researchers have discovered that a signaling molecule called SCUBE3 potently stimulates hair growth and may offer a therapeutic treatment for androgenetic alopecia, a common form of hair loss in both women and men.

The study, published online today in Developmental Cell, determined the precise mechanism by which the dermal papilla cells specialized signal-making fibroblasts at the bottom of each hair follicle promote new growth. Although its well known that dermal papilla cells play a pivotal role in controlling hair growth, the genetic basis of the activating molecules involved has been poorly understood.

At different times during the hair follicle life cycle, the very same dermal papilla cells can send signals that either keep follicles dormant or trigger new hair growth, said Maksim Plikus, Ph.D., UCI professor of developmental & cell biology and the studys corresponding author. We revealed that the SCUBE3 signaling molecule, which dermal papilla cells produce naturally, is the messenger used to tell the neighboring hair stem cells to start dividing, which heralds the onset of new hair growth.

The production of activating molecules by the dermal papilla cells is critical for efficient hair growth in mice and humans. In people with androgenetic alopecia, dermal papilla cells malfunction, greatly reducing the normally abundant activating molecules. A mouse model with hyperactivated dermal papilla cells and excessive hair, which will facilitate more discoveries about hair growth regulation, was developed for this research.

Studying this mouse model permitted us to identify SCUBE3 as the previously unknown signaling molecule that can drive excessive hair growth, said co-first author Yingzi Liu, a UCI postdoctoral researcher in developmental & cell biology.

Further tests validated that SCUBE3 activates hair growth in human follicles. Researchers microinjected SCUBE3 into mouse skin in which human scalp follicles had been transplanted, inducing new growth in both the dormant human and surrounding mouse follicles.

These experiments provide proof-of-principle data that SCUBE3 or derived molecules can be a promising therapeutic for hair loss, said co-first author Christian Guerrero-Juarez, a UCI postdoctoral researcher in mathematics.

Currently, there are two medications on the market finasteride and minoxidil that are approved by the Food and Drug Administration for androgenetic alopecia. Finasteride is only approved for use in men. Both drugs are not universally effective and need to be taken daily to maintain their clinical effect.

There is a strong need for new, effective hair loss medicines, and naturally occurring compounds that are normally used by the dermal papilla cells present ideal next-generation candidates for treatment, Plikus said. Our test in the human hair transplant model validates the preclinical potential of SCUBE3.

UCI has filed a provisional patent application on the use of SCUBE3 and its related molecular compounds for hair growth stimulation. Further research will be conducted in the Plikus lab and at Amplifica Holdings Group Inc., a biotechnology company co-founded by Plikus.

The study team included health professionals and academics from UCI, San Diego, China, Japan, Korea and Taiwan.

This work was supported by LEO Foundation grants LF-AW-RAM-19-400008 and LF-OC-20-000611; Chan Zuckerberg Initiative grant AN-0000000062; W.M. Keck Foundation grant WMKF-5634988; National Science Foundation grants DMS1951144 and DMS1763272; National Institutes of Health grants U01-AR073159, R01-AR079470, R01-AR079150, R21-AR078939 and P30-AR075047; Simons Foundation grant 594598; the National Natural Science Foundation of China; the NNSFCs Major Research Plan training program; and Taiwans Ministry of Science and Technology.

About UCIs Brilliant Future campaign:Publicly launched on Oct. 4, 2019, the Brilliant Future campaign aims to raise awareness and support for UCI. By engaging 75,000 alumni and garnering $2 billion in philanthropic investment, UCI seeks to reach new heights of excellence instudent success, health and wellness, research and more. The School of Biological Sciences plays a vital role in the success of the campaign. Learn more by visitinghttps://brilliantfuture.uci.edu/school-of-biological-sciences.

About the University of California, Irvine:Founded in 1965, UCI is the youngest member of the prestigious Association of American Universities and is ranked among the nations top 10 public universities byU.S. News & World Report. The campus has produced five Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 36,000 students and offers 224 degree programs. Its located in one of the worlds safest and most economically vibrant communities and is Orange Countys second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide.For more on UCI, visitwww.uci.edu.

Media access: Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UCI faculty and experts, subject to availability and university approval. For more UCI news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.

View post:
UCI-led team discovers signaling molecule that potently stimulates hair growth - UCI News

Posted in California Stem Cells | Comments Off on UCI-led team discovers signaling molecule that potently stimulates hair growth – UCI News

Organoids reveal similarities between myotonic dystrophy type 1 and Rett syndrome – EurekAlert

Posted: July 3, 2022 at 2:23 am

Myotonic dystrophy type 1 (DM1) is the most common form of muscular dystrophy, characterized by progressive muscle wasting and weakness and caused by abnormally repetitive DNA segments that are transcribed into toxic molecules of RNA. Instead of ferrying a gene's instructions for translation into proteins, these RNA molecules accumulate in cells, disrupting cellular machinery.

Rett syndrome (RS) is a rare genetic neurological disorder that affects the way the brain develops, resulting in progressive loss of motor skills and language early in life.

Writing in the June 29, 2022 online issue of Science Translational Medicine, researchers at University of California San Diego School of Medicine used three-dimensional brain organoids self-organized tissue grown from stem cells that mimics neurological functions to discover fundamental similarities between DM1 and RS, and perhaps therapeutic opportunities.

"We turned to 3D brain organoids that simulate the developing human cortex to study the effects of the CTG repeat expansion on neuronal processes," said first author Kathryn Morelli, PhD, a fellow in the lab of senior author Gene Yeo, PhD, professor of cellular and molecular medicine at UC San Diego School of Medicine.

"It's a model that can be made from induced pluripotent stem cell lines from real DM1 patients that carry these toxic RNA aggregates. It mimics cortical development in utero."

Unlike other types of muscular dystrophy, patients with DM1 often exhibit progressive neurocognitive symptoms, with learning and social impediments that can appear similar to autism spectrum disorders. Recent clinical data has shown that the higher the number of inherited DNA repeats, the earlier the onset of symptoms and the greater the impact of the disease on the central nervous system.

Modern DM1 treatments target only skeletal and heart muscle defects. Research by Yeo and colleagues has shown that RNA-targeting CRISPR/Cas proteins can bind to repetitive RNA in live human cells and reverse markers of disease in the skeletal muscle of mouse models of DM1.

Still, the absence of a cellular model of the human brain limited our understanding of how toxic RNA can cause cognitive symptoms, and hindered efforts to develop an effective holistic therapy, said Morelli.

In the latest study, researchers packaged a compact RNA-targeting CRISPR/Cas protein into viral vectors, then added them to DM1 brain organoids. They found that the proteins destroyed toxic RNA aggregates, with scientists able to observe and control the cascade of events.

The team has focused on a model in which toxic RNA traps a special class of proteins called RNA binding proteins or RBPs. "In cortical organoids, we were surprised to find that another RBP called CELF2 protein was dysregulated in glutamatergic neurons, which are responsible for excitatory signaling in the brain," said Yeo.

Using the enhanced cross-linking and immunoprecipitation technologies pioneered in the lab, Morelli and colleagues discovered that CELF2 did not bind its normal targets: genes in the methyl-CpG binding protein 2 (MECP2) pathway that are crucial for neuron function. Mutations that result in the loss of MECP2's normal function cause RS.

The findings, said the authors, suggestion a possible convergence in neurodevelopment defects in DM1 and RS. Morelli noted that clinical trials are underway to evaluate the therapeutic potential of N-methyl-d-aspartic acid (NMDA) antagonists for treating patients with RS. NMDA receptors are believed to be important in controlling synaptic plasticity and mediating learning and memory functions.

In DM1 organoids, Morelli found that NMDA antagonists reversed key features of the disease, suggesting that targeting NMDA receptors might ameliorate cognitive impairments in young patients with DM1, and substantially improve their quality of life.

Co-authors include: Wenhao Jin, Shashank Shathe, Assael A. Madrigal, Krysten L. Jones, Joshua L. Schwartz, Tristan Bridges, Jasmine R. Mueller, Archana Shankar, Isaac A. Chaim, all at UC San Diego; and John W. Day, Stanford University.

# # #

Science Translational Medicine

29-Jun-2022

Yeo is a co-founder, member of the board of directors, equity holder and paid consultant for Locanabio and BioInnovations, and a Scientific Adviser and paid consultant to Jumpcode Genomics. He is also a Distinguished Visiting Professor at the National University of Singapore.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Originally posted here:
Organoids reveal similarities between myotonic dystrophy type 1 and Rett syndrome - EurekAlert

Posted in California Stem Cells | Comments Off on Organoids reveal similarities between myotonic dystrophy type 1 and Rett syndrome – EurekAlert

Calidi Biotherapeutics Announces Appointment of W.K. Alfred Yung, M.D., to its Medical Advisory Board – Business Wire

Posted: July 3, 2022 at 2:23 am

LA JOLLA, Calif.--(BUSINESS WIRE)--Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company that is pioneering the development of stem cell-based delivery of oncolytic viruses, today announced the appointment of W.K. Alfred Yung, M.D., Professor, Neuro-Oncology at the MD Anderson Cancer Center, to its Medical Advisory Board.

We are inspired by clinician-scientists like Dr. Yung who have dedicated their careers to advancing care for patients with deadly cancers, such as glioblastoma, for which there are few effective treatments, said Allan J. Camaisa, Chief Executive Officer and Chairman of Calidi. As clinical trials studying the safety and efficacy of Calidis oncolytic virus-based therapies progress, the expertise of seasoned clinicians like Dr. Yung will help us further our understanding of the benefits of these drugs to patients.

Dr. Yung is a fixture in the treatment of brain cancers with extensive experience studying glioblastoma, the deadliest form of brain cancer. He built the neuro-oncology department at MD Anderson Cancer Center, served as co-chair of the National Cancer Institute Brain Malignancy Steering Committee, and advised President Bidens Cancer Moonshot Initiative. Dr. Yung has published more than 350 peer-reviewed articles and served as the editor-in-chief of Neuro-Oncology.

Despite many promising new advancements in precision medicine for many cancers, glioblastoma remains one of the deadliest cancers with limited treatment successes and poor patient quality of life, said W. K. Alfred Yung, M.D. I see great promise in the potential of Calidi Biotherapeutics therapeutic vaccine which shields cancer-fighting oncolytic viruses in stem cells, helping protect the virus from a patients immune system until it reaches the cancer cell. If this approach proves successful in human trials, it could be a game changer not just for the treatment of brain cancers, but for other solid tumor cancers too.

About Calidi Biotherapeutics

Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that is revolutionizing the effective delivery of oncolytic viruses for targeted therapy against difficult-to-treat cancers. Calidi Biotherapeutics is advancing through the FDA approval process a potent allogeneic stem cell and oncolytic virus combination for use in multiple oncology indications. Calidis off-the-shelf, universal cell-based delivery platform is designed to protect, amplify, and potentiate oncolytic viruses currently in development leading to enhanced efficacy and improved patient safety. Calidi Biotherapeutics is headquartered in La Jolla, California. For more information, please visit http://www.calidibio.com.

Forward-Looking Statement

This press release contains forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Terms such as anticipates, believe, continue, could, estimate, expect, intends, may, might, plan, possible, potential, predicts, project, should, would as well as similar terms, are forward-looking in nature. The forward-looking statements contained in this discussion are based on the Calidis current expectations and beliefs concerning future developments and their potential effects. There can be no assurance that future developments affecting Calidi will be those that it has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond Calidis control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any subsequent definitive agreements with respect to the business combination (the Business Combination) with Edoc Acquisition Corp. (Edoc); the outcome of any legal proceedings that may be instituted against Edoc, Calidi, the combined company or others following the announcement of the Business Combination, the private placement financing proposed to be consummated concurrently with the Business Combination (the PIPE), and any definitive agreements with respect thereto; the inability to complete the Business Combination due to the failure to obtain approval of the shareholders of Edoc, the possibility that due diligence completed following execution of the principal definitive transaction documents for the Business Combination and PIPE will not be satisfactorily concluded, the inability to complete the PIPE or other financing needed to complete the Business Combination, or to satisfy other conditions to closing; changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination; the ability to meet stock exchange listing standards following the consummation of the Business Combination; the risk that the Business Combination disrupts current plans and operations of Calidi as a result of the announcement and consummation of the Business Combination; the ability to recognize the anticipated benefits of the Business Combination or to realize estimated pro forma results and underlying assumptions, including with respect to estimated shareholder redemptions; costs related to the Business Combination; changes in applicable laws or regulations; the evolution of the markets in which Calidi competes; the inability of Calidi to defend its intellectual property and satisfy regulatory requirements; the ability to implement business plans, forecasts, and other expectations after the completion of the proposed Business Combination, and identify and realize additional opportunities; the risk of downturns and a changing regulatory landscape in the highly competitive pharmaceutical industry; the impact of the COVID-19 pandemic on Calidis business; and other risks and uncertainties set forth in the section entitled Risk Factors and Cautionary Note Regarding Forward-Looking Statements in Edocs preliminary prospectus dated March 16, 2022, in the Registration Statement on Form S-4 filed with the Securities and Exchange Commission (SEC) on March 16, 2022.

Important Information About the Business Combination Transaction and Where to Find It

This press release relates to a proposed business combination between Edoc Acquisition Corp. a Cayman Islands exempted company, EDOC Merger Sub Inc., a Nevada corporation and Calidi Biotherapeutics, Inc., a Nevada corporation. A full description of the terms and conditions Agreement and Plan of Merger constituting the business combination is provided in the registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission (SEC) by Edoc Acquisition Corp., that includes a prospectus with respect to the securities to be issued in connection with the merger, and information with respect to an extraordinary meeting of Edoc Acquisition Corp. shareholders to vote on the merger and related transactions. Edoc Acquisition Corp. and Calidi Biotherapeutics, Inc. urges its investors, shareholders and other interested persons to read the proxy statement and prospectus as well as other documents filed with the SEC because these documents will contain important information about Calidi Biotherapeutics, Inc., Edoc Acquisition Corp., and the business combination transaction. After the registration statement is declared effective, the definitive proxy statement and prospectus to be included in the registration statement will be distributed to shareholders of Edoc Acquisition Corp. and Calidi Biotherapeutics, Inc., as of a record date to be established for voting on the proposed merger and related transactions. Shareholders may obtain a copy of the Form S-4 registration statement, including the proxy statement and prospectus, and other documents filed with the SEC without charge, by directing a request to: Edoc Acquisition Corp. at 7612 Main Street Fishers, Suite 200, Victor, New York 14564. The preliminary and definitive proxy statement and prospectus included in the registration statement can also be obtained, without charge, at the SECs website (www.sec.gov).

Participation in the Solicitation

Edoc Acquisition Corp., Calidi Biotherapeutics, Inc., and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies or consents from Edoc Acquisition Corp. and Calidi Biotherapeutics, Inc. shareholders in connection with the proposed transaction. A list of the names of the directors and executive officers of Edoc Acquisition Corp. and Calidi Biotherapeutics, Inc. and information regarding their interests in the business combination transaction is contained in the proxy statement and prospectus. You may obtain free copies of these documents as described in the preceding paragraph.

No Offer or Solicitation

This press release will not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed business combination. This press release will also not constitute an offer to sell or the solicitation of an offer to buy any securities of Calidi Biotherapeutics, Inc., nor will there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities will be made except by means of a prospectus meeting the requirements of section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

Read the original here:
Calidi Biotherapeutics Announces Appointment of W.K. Alfred Yung, M.D., to its Medical Advisory Board - Business Wire

Posted in California Stem Cells | Comments Off on Calidi Biotherapeutics Announces Appointment of W.K. Alfred Yung, M.D., to its Medical Advisory Board – Business Wire

Our View: Roe reversal hard hit to science – The Durango Herald

Posted: July 3, 2022 at 2:23 am

Its open season on fundamental rights, now that the Supreme Court has reversed Roe v. Wade and other landmark abortion rights cases, despite more than 60% of Americans saying abortion should be legal in all or most cases.

For those in favor of this ruling, were not hearing them cheer on the decision from a constitutional position. Instead, its based on religious and moral beliefs. Weve prayed and lobbied for this for 50 years, they say. As states scramble to regulate or eliminate abortion, we see more fallout to come.

One being, the high courts decision is disastrous for science.

The vast world of medical research, procedures and the development of critical medicines and vaccines will be severely impacted. This advanced work relies on human fetal tissue.

Fetal tissue obtained from elective abortions is uniquely adaptable and valuable to medical researchers. The tissue has been crucial in understanding normal fetal development and studies of neurological and infectious diseases, including HIV, heart disease, diabetes, Parkinson's and COVID-19. Common vaccines, such as chicken pox, rubella and shingles, were created using human fetal tissue.

Lawrence Goldstein, a distinguished professor at the University of California San Diego School of Medicine, told NPR that because fetal cells are not fully developed, they are useful in, for example, developing replacement organs.

If you're trying to make a kidney from stem cells, you'd like to know that as the cells begin going down the kidney development path that they're doing it normally," Goldstein said. Comparison to early fetal kidney cells that are doing it normally tells you that you're on the right track or not."

In 2021, the Biden administration reversed restrictions on fetal tissue research put in place by former President Trump in 2019. In the throes of the pandemic, Trump basically ended highly meritorious research projects that had already been through multiple layers of scientific and ethical reviews.

In March 2020, research institutions and medical foundations appealed to the Trump administration to lift restrictions to enable COVID-19 studies. We can only speculate how many lives may have been saved, schools kept open, and businesses and economies left to thrive if researchers had the opportunity to do the work directly in front of them. The World Health Organization estimates the number of global deaths attributable to the COVID-19 pandemic in 2020 alone is at least 3 million.

After restrictions were lifted, the U.S. National Institutes of Health no longer had to adhere to both a ban on studies and an ethical review from conservative board members opposed to abortion. Proponents of human fetal tissue research argue this endeavor is morally separate from abortion.

Longstanding, required ethical processes were already in place before the Trump administration stacked this board. The board became the place where federal funding applications went to die. Board members prevented work based on religious and moral grounds.

Conservative judges acted in this same way. The dissent opinion (by Justices Stephen Breyer, Elena Kagan and Sonia Sotomayor) said it plainly: The majority makes radical change too easy and too fast, based on nothing more than the new views of new judges. The majority has overruled Roe and Casey for one and only one reason: because it has always despised them, and now it has the votes to discard them. The majority thereby substitutes a rule by judges for the rule of law.

Giving a subject in a human trial or patient a drug thats already been tested on human tissue in a Petri dish is less likely to cause harm. This is socially responsible and for the greater good.

Consequences from the reversal of Roe v. Wade will continue to creep into our lives. The hard hit to scientific research is just one of them.

See the article here:
Our View: Roe reversal hard hit to science - The Durango Herald

Posted in California Stem Cells | Comments Off on Our View: Roe reversal hard hit to science – The Durango Herald

Huntsville native among TIMEs 100 most influential people – WHNT News 19

Posted: July 3, 2022 at 2:21 am

HUNTSVILLE, Ala. (WHNT) Its an honor only 100 people get every year, a spot on TIMEs most influential people list. This year, a scientist from Huntsville earned that honor because of her work on the Human Genome Project.

Karen Miga is a Buckhorn High School graduate. She told News 19 that her teachers and experiences throughout high school in the Rocket City shaped her into the researcher and scientist she is today.

After high school, Karen got her Bachelors of Science degree at The University of Tennessee before heading to Cleveland, Ohio and getting a Masters Degree in Genetics at Case Western University. Afterward, she headed to Duke University and obtained her Ph.D. in Evolutionary Genetics.

Now, Karen is an Assistant Professor at The University of California, Santa Cruz teaching Biomolecular Engineering. But, TIME is recognizing Karen for her work on the Human Genome Project.

The human genome was first mapped in 2001, but according to scientists, it was not entirely accurate nor complete. So, Karen helped lead a team of international scientists, known as the Telomere-to-Telomere Consortium, or T2T, to complete the first gapless sequence of the human genome.

I started my career when the human genome was first announced and it was clear to me at the time there were large and persistent gaps that the rest world, except for some in the scientific community, were largely ignoring, Karen told News 19.

So, before she became a co-founder of the T2T consortium she was already building a career studying the human genome sequence gaps. Through her studies, she knew there was a lot more to explore.

When I finally reached a point where I knew technology could close some of these regions, thats when I was able to team up with Adam Phillipe who is the other co-founder and is involved with the computational putting together really difficult parts of the genome, Karen explained. So, its this balanced expertise of knowing about these sequences, studying them, then the computational process.

Karen credits a lot of her excitement for science with growing up in the Rocket City. Huntsville has always been this champion for research, she told News 19. Theres always been a tremendous amount of PhDs and folks who are rocket scientists around and there is an appreciation for science.

Karen joins many influential names on the list including President Biden, Ketanji Brown Jackson who was confirmed to fill retiring Justice Stephen Breyers seat, and singer Adele, among many others. She told News 19 TIMEs willingness to diversify who they consider influential is imperative for the science industry.

I think theyve been consistently putting science on the same platform with these important milestones met politically, as well as artists and folks who are making a difference with law in our legal system and Supreme Court Justices, Karen explained.

She also believes the COVID-19 pandemic opened peoples eyes to the importance of science. Weve all seen with the pandemic how important science is and what it means to have a vaccine and the health risks, Karen shared. Science is so important to every aspect of our life but we dont get a lot of exposure to the scientists themselves.

She hopes the upcoming elementary and high school students in the Rocket City take advantage of the research and opportunities around them.

Most of us who are getting these awards started with a single step forward, with a question we were passionate about, building that type of momentum over time, itll pay off, and its never easy and never a direct path but the process of getting there is really an enriching thing, Karen said.

Karens words to those with big dreams, Goals can sometimes seem daunting when you are young, but with continuous hard work, you can change the world.

Read the original:
Huntsville native among TIMEs 100 most influential people - WHNT News 19

Posted in Human Genetics | Comments Off on Huntsville native among TIMEs 100 most influential people – WHNT News 19

Page 357«..1020..356357358359..370380..»